Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 8/2005

01-06-2005

Inhibition of cyclooxygenase-2 suppresses invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 and CD44

Authors: Yuriko Kinugasa, Masashi Hatori, Hidetoshi Ito, Yuji Kurihara, Daisuke Ito, Masao Nagumo

Published in: Clinical & Experimental Metastasis | Issue 8/2005

Login to get access
Metadata
Title
Inhibition of cyclooxygenase-2 suppresses invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 and CD44
Authors
Yuriko Kinugasa
Masashi Hatori
Hidetoshi Ito
Yuji Kurihara
Daisuke Ito
Masao Nagumo
Publication date
01-06-2005
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 8/2005
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-005-1190-x

Other articles of this Issue 8/2005

Clinical & Experimental Metastasis 8/2005 Go to the issue

Acknowledgements

Acknowledgements

Review

Roles for neuregulins in human cancer

OriginalPaper

Syngeneic lymph-node-targeting model of green fluorescent protein-expressing Lewis lung carcinoma

OriginalPaper

Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis

OriginalPaper

Association of α v β 3 integrin expression with the metastatic potential and migratory and chemotactic ability of human osteosarcoma cells

OriginalPaper

Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits